This is a paid advertisement for legal services. Sponsor and responsible law firm: JAG Legal Group, using the 1-800-LAW-FIRM brand.

Do not stop taking a prescribed medication without first consulting with your doctor. Discontinuing a prescribed medication without your doctor’s advice can result in injury or death. Consult your physician before making any decision regarding prescribed medication or medical treatment.

Gabapentin and pregabalin remain FDA-approved for their approved indications. This advertisement is not an FDA notice or a product recall. Research findings do not establish that a medicine caused an individual injury. Jurisdiction and representation disclosures.

LEGAL INFORMATION FOR PATIENTS & FAMILIES Attorney advertising · JAG Legal Group
THE RESOURCE LIBRARY

Clear information.
More confident next steps.

Research explained in plain language, safety information and practical help for families.

LITIGATION EXPLAINED / NOVEMBER 16, 2026

A Philadelphia gabapentinoid complaint: allegations, dates and limits

A September 25 complaint discussed in November names gabapentin and pregabalin. It is an allegation, not a ruling that either medicine caused dementia.

Read the guide ↗
GUIDE / NOVEMBER 9, 2026

Gabapentinoids after fracture surgery: reading the evidence carefully

An October study raises questions about healing after surgery, but cannot establish that gabapentin caused an individual complication.

Read the guide ↗
GUIDE / NOVEMBER 9, 2026

Gabapentin litigation headlines: what a court record can tell you

Understand the November federal MDL report, the limits of lawsuit headlines and why deadlines require individual review.

Read the guide ↗
RESEARCH & SAFETY / NOVEMBER 2, 2026

October 28 cancer-itch study: what it can and cannot tell us

A new study examined symptom relief and adverse events in cancer care; it does not settle questions about dementia.

Read the guide ↗
RESEARCH & SAFETY / NOVEMBER 2, 2026

Gabapentin label dates: a recent posting is not always a new warning

Understand the difference between a label posting date, a revision date and an FDA action before interpreting a safety headline.

Read the guide ↗
GUIDE / OCTOBER 26, 2026

What the October prescribing study means

Understand why a study of existing dementia does not establish new-onset injury.

Read the guide ↗
GUIDE / OCTOBER 26, 2026

Identify your medication and manufacturer

Build an accurate record of the product, fills and diagnosis timeline.

Read the guide ↗
RESEARCH / OCTOBER 24, 2026

Reading the dementia research

Understand what observational studies can establish and where uncertainty remains.

Read the guide ↗
PATIENT GUIDE / OCTOBER 24, 2026

Your legal review checklist

Find the prescription, diagnosis and timeline information worth preserving.

Read the guide ↗
LEGAL GUIDE / OCTOBER 24, 2026

Understanding a potential claim

Learn why a review depends on the product, medical evidence and applicable law.

Read the guide ↗

Explore injury concerns

Go directly to the sources

Our guides link to the underlying medical publications and FDA materials so you can read them in context. Summaries are general information and are not medical advice.

YOUR NEXT STEP

You don’t have to sort
through this alone.

Talk through your concerns and learn what information a legal review may require.

Call 1-800-LAW-FIRM ↗

1-800-529-3476 · No obligation to retain a lawyer

Request a reviewCall 1-800-LAW-FIRM ↗